National Health Investors, Inc. (NYSE:NHI – Get Free Report)’s share price hit a new 52-week high during trading on Wednesday . The company traded as high as $87.27 and last traded at $86.1710, with a volume of 287109 shares changing hands. The stock had previously closed at $85.10.
Analyst Upgrades and Downgrades
A number of research firms recently issued reports on NHI. Weiss Ratings reiterated a “buy (b)” rating on shares of National Health Investors in a report on Monday, December 29th. KeyCorp raised their price target on shares of National Health Investors from $80.00 to $88.00 and gave the stock an “overweight” rating in a research note on Thursday, December 4th. National Bankshares set a $85.00 price objective on shares of National Health Investors in a report on Tuesday, January 20th. Deutsche Bank Aktiengesellschaft cut shares of National Health Investors from a “buy” rating to a “hold” rating and set a $85.00 target price for the company. in a report on Tuesday, January 20th. Finally, Wells Fargo & Company lifted their price target on shares of National Health Investors from $80.00 to $85.00 and gave the company an “equal weight” rating in a research note on Tuesday, November 25th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, National Health Investors presently has an average rating of “Moderate Buy” and a consensus target price of $85.57.
Get Our Latest Analysis on National Health Investors
National Health Investors Stock Up 1.3%
Hedge Funds Weigh In On National Health Investors
A number of institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its position in National Health Investors by 0.8% during the third quarter. Vanguard Group Inc. now owns 6,498,414 shares of the real estate investment trust’s stock worth $516,624,000 after acquiring an additional 52,474 shares in the last quarter. State Street Corp increased its stake in shares of National Health Investors by 5.0% during the 2nd quarter. State Street Corp now owns 2,023,381 shares of the real estate investment trust’s stock worth $143,651,000 after purchasing an additional 95,812 shares during the last quarter. Principal Financial Group Inc. raised its holdings in shares of National Health Investors by 1.9% in the 4th quarter. Principal Financial Group Inc. now owns 1,668,006 shares of the real estate investment trust’s stock valued at $127,386,000 after purchasing an additional 30,968 shares during the period. JPMorgan Chase & Co. lifted its stake in National Health Investors by 34.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,613,051 shares of the real estate investment trust’s stock valued at $128,238,000 after purchasing an additional 409,559 shares during the last quarter. Finally, Geode Capital Management LLC grew its holdings in National Health Investors by 1.5% during the fourth quarter. Geode Capital Management LLC now owns 1,262,657 shares of the real estate investment trust’s stock worth $96,443,000 after purchasing an additional 18,198 shares during the period. 62.51% of the stock is currently owned by institutional investors and hedge funds.
National Health Investors Company Profile
National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.
Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.
Further Reading
- Five stocks we like better than National Health Investors
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- The day the gold market broke
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.
